Clinical Trial Update: Study to Investigate Efficacy and Safety of Adalimumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the efficacy and safety of adalimumab in Japanese subjects with generalized pustular psoriasis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Pustular Psoriasis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: AbbVie | Conditions: Generalized Pustular Psoriasis (GPP), Adalimumab | Phase 3 | Status: COMPLETED | Results posted: 2019-01-14